LPCN Insider Trading Activity and SEC Form 4 Filings
LPCN insider trading summary
Over the past 12 months, insiders at Lipocine Inc. (LPCN) reported 7 open-market purchases worth $517K by 2 insiders and no sales on SEC Form 4. Net insider buying was $517K.
Latest LPCN insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 30, 2026 | John W. Higuchi | Director | Buy | $36K (15,970 @ $2.23) |
| Sep 29, 2026 | John W. Higuchi | Director | Buy | $19K (9,037 @ $2.15) |
| Sep 28, 2026 | John W. Higuchi | Director | Buy | $27K (12,561 @ $2.16) |
| Apr 7, 2026 | John W. Higuchi | Director | Buy | $81K (40,000 @ $2.03) |
| Apr 6, 2026 | Mahesh V. Patel | Chief Executive Officer | Buy | $51K (25,000 @ $2.03) |
| Apr 6, 2026 | John W. Higuchi | Director | Buy | $252K (123,000 @ $2.05) |
| Apr 2, 2026 | Mahesh V. Patel | Chief Executive Officer | Buy | $51K (25,000 @ $2.02) |
| May 25, 2023 | Mahesh V. Patel | CEO and President | Buy | $44K (8,706 @ $5.03) |
| Mar 24, 2023 | Mahesh V. Patel | CEO and President | Buy | $48K (150,000 @ $0.32) |
| Mar 20, 2023 | Richard Dana Ono | Director | Buy | $1K (4,000 @ $0.34) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.